Extended resections for hilar cholangiocarcinoma

被引:578
|
作者
Neuhaus, P
Jonas, S
Bechstein, WO
Lohmann, R
Radke, C
King, N
Wex, C
Lobeck, H
Hintze, R
机构
[1] Humboldt Univ, Dept Surg, Charite Virchow Klinikum, Inst Pathol, D-13353 Berlin, Germany
[2] Humboldt Univ, Dept Gen Surg, Charite Virchow Klinikum, Inst Pathol, D-13353 Berlin, Germany
[3] Humboldt Univ, Dept Visceral Surg, Charite Virchow Klinikum, Inst Pathol, D-13353 Berlin, Germany
[4] Humboldt Univ, Dept Transplantat Surg, Charite Virchow Klinikum, Inst Pathol, D-13353 Berlin, Germany
关键词
D O I
10.1097/00000658-199912000-00010
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To evaluate different strategies for extended resections of hilar cholangiocarcinomas on radicality and survival. Summary Background Data Surgical resection of hilar cholangiocarcinoma is the only potentially curative treatment. Resection of central bile duct car cinemas. however, cannot always comply with the general principles of surgical oncology to achieve wide tumor-free margins with no-touch techniques. Methods From 1988 to 1998, 95 patients underwent resection of hilar cholangiocarcinoma. Eighty patients had hilar and hepatic resections and 15 had liver transplantation and partial pancreatoduodenectomy (LTPP; i.e., eradication of the entire biliary tract using a no-touch technique). Results The 60-day death rate was 8%. The overall 1- and 5-year survival rates were 67% and 22%, respectively. Five-year survival rates after RO, R1, and R2 resections were 37%, 9%, and 0%. in a multivariate analysis, surgical radicality was the strongest determinant of survival (p < 0.001). The rate of formally curative resection (RO resection) was significantly lower in hilar resections (29%) than in liver resections (left hemihepatectomy 59%, right hemihepatectomy 55%, right trisegmentectomy 65%; p < 0.05). The highest rate of RO resection was observed after LTPP (93%; p < 0.05). Right trisegmentectomies achieved the highest rate of 5-year survival after RO resection (57%). In a multivariate analysis of patient survival after RO resection, additional portal Vein resection was the only significant factor. The 5-year survival rate after formally curative liver resection with portal vein resection was 65% versus 28% without. Conclusion Extended resections, especially right trisegmentectomies and LTPP, resulted in the highest rate of R0 resection. Right trisegmentectomy together with portal vein resection best represents the principles of surgical oncology and may be regarded as the surgical pR0cedure of choice. Immunosuppression limits the applicability of LTPP.
引用
收藏
页码:808 / 818
页数:11
相关论文
共 50 条
  • [41] The Landmark Series: Hilar Cholangiocarcinoma
    Soares, Kevin C.
    Jarnagin, William R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4158 - 4170
  • [42] STAGING OF HILAR CHOLANGIOCARCINOMA WITH ULTRASOUND
    NEUMAIER, CE
    BERTOLOTTO, M
    PERRONE, R
    MARTINOLI, C
    LORIA, F
    SILVESTRI, E
    [J]. JOURNAL OF CLINICAL ULTRASOUND, 1995, 23 (03) : 173 - 178
  • [43] The Landmark Series: Hilar Cholangiocarcinoma
    Kevin C. Soares
    William R. Jarnagin
    [J]. Annals of Surgical Oncology, 2021, 28 : 4158 - 4170
  • [44] Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): Extended resection is associated with improved survival
    van Gulik, T. M.
    Kloek, J. J.
    Ruys, A. T.
    Busch, O. R. C.
    van Tienhoven, G. J.
    Lameris, J. S.
    Rauws, E. A. J.
    Gouma, D. J.
    [J]. EJSO, 2011, 37 (01): : 65 - 71
  • [45] Palliative surgery for hilar cholangiocarcinoma
    Hai-Min Li
    Ke-Feng Dou
    Kai Sun
    Zhi-Qing Gao
    Kai-Zong Li
    You-Chi Fu the Department of Hepatobiliary Surgery
    [J]. Hepatobiliary & Pancreatic Diseases International, 2003, (01) : 110 - 113
  • [46] Issues in Surgery for Hilar Cholangiocarcinoma
    Shah, Sudeep R.
    [J]. INDIAN JOURNAL OF SURGERY, 2012, 74 (01) : 87 - 90
  • [47] Liver transplantation for hilar cholangiocarcinoma
    Rauchfuss, F.
    Utess, F.
    Schuele, S.
    Dittmar, Y.
    Scheuerlein, H.
    Settmacher, U.
    [J]. CHIRURG, 2012, 83 (03): : 229 - +
  • [48] Liver transplantation for hilar cholangiocarcinoma
    Ricardo Robles
    Francisco Sánchez-Bueno
    Pablo Ramírez
    Roberto Brusadin
    Pascual Parrilla
    [J]. World Journal of Gastroenterology, 2013, (48) : 9209 - 9215
  • [49] Hilar Cholangiocarcinoma: Current Management
    Ito, Fumito
    Cho, Clifford S.
    Rikkers, Layton F.
    Weber, Sharon M.
    [J]. ANNALS OF SURGERY, 2009, 250 (02) : 210 - 218
  • [50] Current therapy of hilar cholangiocarcinoma
    Lau, Stephanie Hiu Yan
    Lau, Wan Yee
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (01) : 12 - 17